Acetamidine

Acetamidine

SCHEMBL56668

CC(=N)N.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetamidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetamidine SCHEMBL11284223 1.00
Acetamidine SCHEMBL7312145 1.00
Acetamidine SCHEMBL5492042 0.95
Acetamidine SCHEMBL27656467 0.95
Acetamidine SCHEMBL31197659 0.94
Acetamidine SCHEMBL48895 0.94
Acetamidine SCHEMBL8817730 0.89
Acetamidine SCHEMBL19179840 0.89
Acetamidine SCHEMBL3181786 0.89
Acetamidine SCHEMBL10430727 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3192 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250297351-A1 LASER-ASSISTED REAGENT ACTIVATION AND PROPERTY MODIFICATION OF SELF-PASSIVATING METALS SWAGELOK COMPANY 2025-09-25 US claimed
CN-120054414-A Modified Y-type molecular sieve and preparation method thereof 中国石油天然气股份有限公司 2025-05-30 CN claimed
CN-120054595-A Modified Y-type molecular sieve, preparation method thereof and hydrocracking catalyst 中国石油天然气股份有限公司 2025-05-30 CN claimed
CN-120054596-A Modified Y-type molecular sieve, preparation method thereof and hydrocracking catalyst 中国石油天然气股份有限公司 2025-05-30 CN claimed
CN-120054597-A Modified Y-type molecular sieve and preparation method and application thereof 中国石油天然气股份有限公司 2025-05-30 CN claimed
CN-120004697-A Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material 同济大学 2025-05-16 CN claimed
CN-119591548-A Preparation method of 5-bromo (chloro) -2-methylpyrimidine 台州职业技术学院 2025-03-11 CN claimed
CN-117756628-B Method for preparing acetamidine hydrochloride free from aminopyrimidine mother liquor and combining methyl formate 江苏兄弟维生素有限公司 2025-02-21 CN claimed
CN-119403952-A Laser assisted reagent activation and modification of self-passivating metals 斯瓦戈洛克公司 2025-02-07 CN claimed
CN-118591198-A Flexible perovskite solar cell and preparation method thereof 华北电力大学 2024-09-03 CN claimed
US-5075443-A Preparation of 2-amino-4-alkoxy-s-triazines CIBA-GEIGY CORPORATION (US) 1991-12-24 US claimed
US-5070199-A Process for the preparation of 2-amino-4-methyl-6-methoxy-1,3,5-triazine E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-12-03 US claimed
CN-1038815-A The method for preparing Gophacide and series product thereof LIAONING CHEMICAL INST (CN) 1990-01-17 CN claimed
EP-0069883-B1 PROCESS FOR THE PREPARATION OF HYDRAZIDINES BAYER AG (DE) 1984-08-29 EP claimed
US-4443629-A AMIDINES, HYDRAZINE HYDRATE, SOLVENTS BAYER AKTIENGESELLSCHAFT (DE) 1984-04-17 US claimed
EP-0069883-A1 Process for the preparation of hydrazidines BAYER AG (DE) 1983-01-19 EP claimed
US-4312818-A CATALYZED REACTION OF A PHENOL WITH A PHOSPHORUS HALIDE CIBA-GEIGY CORPORATION (US) 1982-01-26 US claimed
EP-0000757-B1 PROCESS FOR THE PREPARATION OF TRIARYLPHOSPHITES CIBA-GEIGY AG (CH) 1981-08-05 EP claimed
EP-0000757-A1 Process for the preparation of triarylphosphites CIBA-GEIGY AG (CH) 1979-02-21 EP claimed
US-3954756-A Method for producing pyrimidine TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-05-04 US claimed